Detalhe da pesquisa
1.
Current and upcoming treatment approaches to common subtypes of PTCL (PTCL NOS, ALCL, TFHs).
Blood
; 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38306597
2.
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
Blood
; 141(18): 2194-2205, 2023 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796016
3.
Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation.
Haematologica
; 109(4): 1149-1162, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646671
4.
Diffuse large B-cell lymphoma involving osseous sites: utility of response assessment by PET/CT and good longterm outcomes.
Haematologica
; 109(1): 200-208, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646672
5.
Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis.
Haematologica
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38752279
6.
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.
Br J Haematol
; 202(3): 525-529, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217196
7.
Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results.
Blood
; 138(6): 427-438, 2021 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33827139
8.
Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era.
Blood
; 137(1): 39-48, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730585
9.
A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas.
Blood
; 138(26): 2828-2837, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34653242
10.
Current Treatment of Peripheral T-cell Lymphoma.
Oncology (Williston Park)
; 36(5): 293-305, 2022 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35576176
11.
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma.
Blood
; 133(20): 2121-2129, 2019 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30770396
12.
Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts.
Am J Hematol
; 96(10): 1211-1222, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34251048
13.
Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
J Am Acad Dermatol
; 85(5): 1093-1106, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945836
14.
Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis.
J Am Acad Dermatol
; 85(5): 1073-1090, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33940098
15.
Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma.
Blood
; 141(22): 2780-2783, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898084
16.
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma.
Blood
; 131(8): 888-898, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29233821
17.
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma.
Blood
; 131(11): 1183-1194, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29229594
18.
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas.
Am J Hematol
; 95(2): 151-155, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31709579
19.
Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sézary syndrome: Retrospective analysis of 157 patients from a referral cancer center.
J Am Acad Dermatol
; 83(2): 430-439, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31499157
20.
Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma.
Br J Haematol
; 204(2): e17-e20, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37905372